Temporary aortic occlusion device
11389168 · 2022-07-19
Assignee
- MicroVention, Inc. (Aliso Viejo, CA, US)
- University Of Virginia Patent Foundation (Charlottesville, VA)
- United States of America as represented by the Secretary of the Navy (Silver Spring, MD, US)
Inventors
- George R. Greene, Jr. (Costa Mesa, CA, US)
- Ivan Sepetka (Los Altos, CA)
- Cathy Lei (Chino Hills, CA, US)
- Rupal Nguyen (Costa Mesa, CA, US)
- Matthew J. Bradley (Silver Spring, MD, US)
- Stephen T. Ahlers (Silver Spring, MD, US)
- Carl S. Goforth (Silver Spring, MD, US)
- James R. Stone (Charlottesville, VA, US)
Cpc classification
A61B90/03
HUMAN NECESSITIES
A61B17/12177
HUMAN NECESSITIES
A61B17/12172
HUMAN NECESSITIES
International classification
A61B17/12
HUMAN NECESSITIES
Abstract
A temporary aortic occlusion device is disclosed, having an expandable locator portion and an expandable occlusion portion. The expandable locator portion assists a user in determining whether the distal end of the device has been advanced within a patient's aorta, and the occlusion portion is expanded to occlude the patient's aorta, preferably below the renal arteries.
Claims
1. A temporary aortic occlusion device, comprising: an elongated device body defining an axis therethrough and having a distal end and a proximal end; a locator portion located near the distal end of the elongated device body, the locator portion having a proximal side and a distal side and being radially expandable from the proximal end of the device so as to confirm a proper location of the temporary aortic occlusion device within an aorta, wherein the locator portion has a maximum expansion diameter configured to be less than the diameter of the aorta; an occlusion portion located near the distal end of the elongated device body, the occlusion portion being radially expandable from the proximal end of the device to a diameter equal to or greater than a diameter of the aorta so as to cause occlusion of the aorta; and a control member extending from the proximal end of the elongated device body to the locator portion, the control member configured to apply a compressive axial force to the locator portion to cause a relative distance between the proximal and distal sides of the locator portion to decrease thereby radially expanding the locator portion.
2. The temporary aortic occlusion device of claim 1, wherein the locator portion is composed of a plurality of braided wires.
3. The temporary aortic occlusion device of claim 1, wherein the occlusion portion is composed of a plurality of braided wires.
4. The temporary aortic occlusion device of claim 1, wherein the occlusion portion is a balloon.
5. The temporary aortic occlusion device of claim 1, wherein the locator portion is positioned proximal of the occlusion portion.
6. The temporary aortic occlusion device of claim 1, wherein the occlusion portion has a maximum expansion diameter configured to be greater than the diameter of the aorta.
7. The temporary aortic occlusion device of claim 1, wherein the maximum expansion diameter of the locator portion is smaller than a maximum expansion diameter of the occlusion portion.
8. The temporary aortic occlusion device of claim 1, wherein the elongated device body is a tube.
9. The temporary aortic occlusion device of claim 8, wherein the control member comprises a control wire positioned within a lumen of the tube controlling radial expansion of the locator portion.
10. The temporary aortic occlusion device of claim 1, further comprising a handle at the proximal end of the device.
11. The temporary aortic occlusion device of claim 10, wherein the handle includes a first slider member controlling radial expansion of the locator portion via the control member.
12. The temporary aortic occlusion device of claim 11, wherein the handle includes a second slider member controlling radial expansion of the occlusion portion.
13. The temporary aortic occlusion device of claim 11, wherein the occlusion portion is a balloon, and the handle further comprises a fluid connection port controlling radial expansion of the balloon.
14. The temporary aortic occlusion device of claim 1, wherein the temporary aortic occlusion device is configured to be located below renal arteries in an aorta.
15. The temporary aortic occlusion device of claim 1, wherein the control member is configured to apply the compressive axial force to the distal side of the locator portion.
16. A temporary aortic occlusion device, comprising: an elongated device body having a distal end and a proximal end; a locator portion located near the distal end of the elongated device body, the locator portion extending axially from a proximal side to a distal side in a delivery configuration and being radially expandable from the proximal end of the device so as to confirm a proper location of the temporary aortic occlusion device within the aorta by resistance, wherein the locator portion has a maximum expansion diameter configured to be less than the diameter of the aorta; an occlusion portion located near the distal end of the elongated device body, the occlusion portion being radially expandable from the proximal end of the device so as to cause occlusion of the aorta; and a handle at the proximal end of the elongated device body, the handle having a first expansion control member configured to control radial expansion of the locator portion by causing a compressive axial force to be applied to the locator portion and a second expansion control member configured to control radial expansion of the occlusion portion.
17. The temporary aortic occlusion device of claim 16, wherein the occlusion portion has a larger maximum expansion diameter than the maximum expansion diameter of the locator portion.
18. The temporary aortic occlusion device of claim 17, wherein the locator portion is positioned proximally of the occlusion portion.
19. The temporary aortic occlusion device of claim 16, wherein the first expansion control member is configured to apply the compressive axial force to the distal side of the locator portion.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) These and other aspects, features and advantages of which embodiments of the invention are capable of will be apparent and elucidated from the following description of embodiments of the present invention, reference being made to the accompanying drawings, in which
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
DESCRIPTION OF EMBODIMENTS
(22) Specific embodiments of the invention will now be described with reference to the accompanying drawings. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. The terminology used in the detailed description of the embodiments illustrated in the accompanying drawings is not intended to be limiting of the invention. In the drawings, like numbers refer to like elements.
(23)
(24) The locator 104 is preferably composed of a wire mesh (e.g., 0.0005″-0.004″ Nitinol wires) braided into a generally tubular shape. A proximal end of the locator 104 is fixed to distal end of a kink-resistant catheter tube 106 and a distal end of the locator 104 is fixed to ring 114, which is also connected to control wire 109. The control wire 109 is positioned within the lumen of the catheter tube 106 and its proximal end is fixed to slider 112. Hence, as the slider 112 is moved proximally, the control wire 109 moves the ring 114 proximally towards the catheter tube 106, causing the locator 104 to expand. The fully expanded locator 104 can be one of many different sizes, each of which designed to have a maximum expansion that is equal to or smaller than the target aorta size (e.g., 18 mm to 25 mm). The mesh of the locator 104 also may include an elastic hydrophilic coating to prevent blood flow from entering the catheter tube 106.
(25) The occlusion portion 102 functions in a similar manner as the locator 104, having a proximal end fixed to ring 114 and a distal end fixed to ring 116. The ring 116 is further connected to control wire 107, which is slidably positioned within the lumen of the catheter tube 106 and has a proximal end connected to slider 110. Hence, as the slider 110 is moved proximally, it causes the occlusion portion 102 to expand.
(26) The occlusion portion 102 is composed of a wire mesh (e.g., (e.g., 0.0005″-0.004″ Nitinol or PET wires) that are laminated, coated (e.g., dip coating), or have a film applied either on its inner surface, outer surface, or both. Coating materials include polyurethane or silicone, and film materials includes polyethylene, linear low-density polyethylene, polyethylene terephthalate, and Nitinol. In one specific example, each of the wires are first coated in a polymer coating (e.g., polyurethane or polyethylene), braided, and then the inner surface of the occlusion portion 102 is completely coated in a thin 10-15 micron film of the same or similar polymer coating. In another specific example, ePTFE is coated on the inner and outer surface of the occlusion portion 102, “sandwiching” its braid. The occlusion portion 102 optionally has a length greater than that of the locator 104, so as to create a sufficient seal with the patient's aorta.
(27) Preferably, the locator 104 and the occlusion portion 102 are spaced to ensure that the occlusion portion 102 does not occlude the renal arteries leading to the kidneys. A preferred average spacing between the two is about 4.00 cm to about 4.50 cm from each other based on the aortic anatomy of a range of average humans. However, it may be desirable to increase this distance in some circumstances (e.g., large patients) or decrease this distance (e.g., young/small patients).
(28) One aspect of the device 100 is that it allows a user to sense whether there is resistance to expanding the locator 104 or not. In this respect, the locator 104 preferably has a maximum diameter expansion that is either the same size as or slightly smaller than the patient's aorta diameter (e.g., 18 mm to 25 mm). This expansion limit can be limited by the length of movement of the slider 112, as well as the construction of the braid. In contrast, the occlusion portion 102 is configured to have a slightly larger maximum expansion diameter than the locator 104 and/or patient's aorta. This allows the occlusion portion 102 to properly engage the aorta and occlude blood flow. If the device 100 only included the occlusion portion 102 and not the locator 104, a user would encounter expansion resistance prior to entering the aorta, as well as in the aorta, which could cause user-confusion about the device's position. By including the locator 104 that will not substantially encounter resistance in the aorta, the user can have a much higher degree of confidence that the device has entered the aorta.
(29) Since the occlusion portion 102 must be capable of expanding within an aorta 1 and applying a reasonably sufficient force again walls of the aorta 1, there is a risk of rupturing or dissecting the smaller vessels connected to the aorta 1 if expanded too soon. In that regard, the locator 104 can be configured to assist expansion only until encountering a predetermined resistance force and/or with a less forceful expansion force. In this regard, the locator 104 can be expanded with less risk of rupturing the smaller, aortic-adjacent vessels.
(30) One way to achieve this reduced expansion force is to compose the locator 104 of relatively fewer braided wires that, when encountering small amounts of force tend to deform or at least provide less force on the vessels (e.g., 36 0.005″ wires for the locator 104 vs. 48 0.005″ wires for the occlusion portion 102). Additionally, as previously mentioned, the locator 104 can be coated or laminated with a polymer material similar to the occlusion portion 102, which can further create resistance to expansion. Providing a relatively thick coating can further disperse force from the wires of the locator 104, thereby further reducing risk of vessel rupture.
(31) An alternate or additional mechanism includes adding a spring or elastic member between the end of the control wire 109 and the ring 114, such that when resistance is encountered by the locator 104, the spring or elastic expands. Alternately or additionally, the entire control wire 109 can be composed of an elastic material that tends to stretch when resistance is encountered by the locator 104. Optionally, similar mechanisms can be included with regard to the occlusion portion 102, though with the ability to apply somewhat greater force before attenuation.
(32) The handle 108 of the device 100 may also include an indicator light 120 that illuminates when the locator 104 has fully expanded. The handle 108 may have a contact or switch that is triggered when the slider 112 is slid to its proximal-most position to thereby indicate that the aorta 1 has been reached by the device 100.
(33) The distal end of the device 100 also includes an atraumatic tip 118 that is fixed to ring 116. In one example, the tip 118 is composed of a helically-wound wire or coil and is sufficiently flexible to avoid injuring the aorta 1 of a patient.
(34) In operation, the device is loaded directly into a femoral sheath and pushed distally from the femoral artery and into the common iliac towards the common iliac artery bifurcation. Once the catheter tip is close to the target, the slider 112 can be used to slow expand the locator 104. If resistance occurs, the slider 112 can be pushed distally to collapse the locator 104 and the device can be further advanced distally. Once the slider 112 can open fully without resistance, the slider 112 activates the light 120. Finally, the slider 110 can be moved proximally to expand the occlusion portion 102, blocking or occluding the aorta.
(35)
(36)
(37)
(38)
(39)
(40)
(41)
(42)
(43) Turning to
(44)
(45)
(46) Preferably, the balloon 208 is composed of a highly compliant material. In this respect, if the balloon 208 is over inflated, it will elongate rather than continuing to apply radial force on the wall of the aorta, thereby avoiding balloon-induced aortic damage.
(47) Although the invention has been described in terms of particular embodiments and applications, one of ordinary skill in the art, in light of this teaching, can generate additional embodiments and modifications without departing from the spirit of or exceeding the scope of the claimed invention. Accordingly, it is to be understood that the drawings and descriptions herein are proffered by way of example to facilitate comprehension of the invention and should not be construed to limit the scope thereof.